Biotechnology Stocks II: Compare Returns of S&P 500 to Y-mAbs Therapeutics, Inc. (YMAB)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and YMAB | ||
---|---|---|
S&P 500 | YMAB | |
Start Date | Nov-01-2018 | Oct-31-2018 |
Start Price | $2,800.75 | $24.56 |
End Date | Apr-11-2025 | Apr-17-2025 |
End Price | $5,363.36 | $4.69 |
Number Monthly Prices | 79 | 79 |
Min Date | Dec-01-2018 | Oct-31-2022 |
Min Price | $3,222.66 | $3.61 |
Max Date | Dec-01-2024 | Nov-30-2020 |
Max Price | $6,010.09 | $50.87 |
Total Return | 57.40% | -80.90% |
Annualized Return | 7.13% | -22.24% |
Current Value of $1,000 Purchase | $1,574 | $191 |
Number Returns | 3,081 | 3,081 |
Average Return | 19.21% | -23.33% |
Minimum Return | -25.54% | -92.90% |
Maximum Return | 86.49% | 362.60% |
Number Profitable Returns | 2,559 | 870 |
Percent Profitable Returns | 83.06% | 28.24% |
Number Unprofitable Returns | 522 | 2,211 |
Percent Unprofitable Returns | 16.94% | 71.76% |
Profitable to Unprofitable Returns Ratio | 4.90 | 0.39 |
YMAB Dollar-cost Average
YMAB Trendline Chart
YMAB Moving Average Chart
YMAB Stock Return Map - See Patterns of Gains and Losses
YMAB Stock Returns/Purchase Dates